With this regard, it has been demonstrated that MEK inhibitors decrease HR repair gene expression, and there is synergistic activity with PARP inhibitors in vitro and in vivo in tumours with mutant RAS [72]. This evidence concerns the gene MAP2K7 and neoplasm.